Related Experiment Videos
HLA-DR/RFLP compatible corneal grafts
K Baggesen1, N Ehlers, L U Lamm
1Department of Ophthalmology, Arhus University Hospital, Denmark.
Acta Ophthalmologica
|April 1, 1991
Insights
Matching human leukocyte antigen (HLA) and RFLP subtypes significantly improves graft survival in high-risk transplantations. This study shows a 93% graft survival rate in matched cases versus 50% in unmatched controls.
Area of Science:
- Transplantation immunology
- Genetics in transplantation
Background:
- Graft survival in high-risk transplantations remains a challenge.
- HLA/DR antigen and RFLP subtype matching are critical factors in transplantation outcomes.
Purpose of the Study:
- To evaluate the impact of HLA/DR antigen and RFLP subtype matching on graft survival in elective high-risk transplantations.
Main Methods:
- Fifty-one elective high-risk transplantations were analyzed.
- Grafts were matched based on human leukocyte antigen (HLA)/DR antigens and RFLP subtypes.
- Survival rates were compared between matched and non-matched compatible historical control groups.
Main Results:
- The 18-month graft survival rate was 93% in the matched group.
- The 18-month graft survival rate was 50% in the non-matched compatible historical control group.
- A significant difference in survival was observed between the two groups.
Conclusions:
- HLA/DR antigen and RFLP subtype matching is crucial for improving graft survival in high-risk transplantations.
- Precise genetic matching can substantially reduce graft rejection rates.
Abstract:
Fifty-one elective high risk transplantations were matched according to HLA/DR antigens and RFLP-subtypes. The 18 months survival of the grafts are 93% in the matched group compared to 50% in a non-matched compatible historical control group.